Upregulated NINL mRNA and protein expression have been observed in several types of human tumors, such as head and neck squamous cell carcinoma (HNSCC), breast cancer, ovarian cancer, and lung cancer (16–21). This evidence concerns the gene NINL and ovarian carcinoma.